Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

China flag China · Delayed Price · Currency is CNY
22.93
-0.34 (-1.46%)
Mar 9, 2026, 3:00 PM CST
Market Cap4.43B -23.7%
Revenue (ttm)958.99M +15.8%
Net Income-563.62M
EPS-2.93
Shares Out193.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,468,931
Average Volume1,867,384
Open23.10
Previous Close23.27
Day's Range22.70 - 23.10
52-Week Range21.14 - 36.00
Beta1.16
RSI37.74
Earnings DateApr 29, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagn... [Read more]

Sector Healthcare
Founded 2005
Employees 2,434
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688298
Full Company Profile

Financial Performance

In 2025, SHA:688298's revenue was 958.99 million, an increase of 15.83% compared to the previous year's 827.92 million. Losses were -563.62 million, 6.54% more than in 2024.

Financial Statements